The current valuation score of Esperion Therapeutics Inc is 9.50, ranking 18 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -1029.13, which is -99.97% below the recent high of -0.32 and -0.31% above the recent low of -1032.36.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.